323EGP
- Active ingredient
- glucagon
- Strength
- 1mg/ml
- Form
- vial
- Manufacturer
- novo nordisk > egyptian pharmaceutical trading company
- Route
- injection
Uses
Indicated for severe hypoglycemia and as a diagnostic aid in selected procedures.
Do not use if
Pheochromocytoma, insulinoma, or hypersensitivity to glucagon.
Side effects
May cause nausea, vomiting, headache, or injection-site reactions.
Warnings
Patients should consume carbohydrates once recovered from hypoglycemia.
How it works
Raises blood glucose by stimulating hepatic glycogen breakdown and glucose release.
Storage
Store according to labeling and protect from excessive heat.
